According to a meta‐analysis conducted in the Asian population, the PD1 (rs36084323) polymorphism was shown to decrease cancer risk, particularly for epithelial ovarian cancer and could serve as a potential biomarker to enhance the screening of high‐risk cancer patients [10]. This evidence concerns the gene PDCD1 and cancer.